RecruitingNot ApplicableNCT04047264

Feasibility of Intraoperative Microdialysis During Neurosurgery for Central Nervous System Malignancies

Intraoperative Microdialysis During Neurosurgery for Central Nervous System Malignancies

Sponsor

Mayo Clinic

Enrollment

100 participants

Start Date

Jan 1, 2020

Study Type

INTERVENTIONAL

Conditions

Metastatic Malignant Neoplasm in the Brain Glioblastoma Glioma

Summary

This clinical trial evaluates the use of microdialysis catheters during surgery to collect biomarkers, and studies the feasibility of intraoperative microdialysis during neurosurgery for central nervous system malignancies. A biomarker is a measurable indicator of the severity or presence of disease state. Information collected in this study may help doctors to develop new strategies to better diagnose, monitor, and treat brain tumors.

Eligibility

Min Age: 18 Years

Inclusion Criteria8

Age \>= 18 years
Diagnosis of the following, based on clinical and radiographic evidence:
Any glioma
Metastatic brain tumor of any primary origin
Epileptic focus requiring surgical resection
Planned neurosurgical procedure for purposes of biopsy or resection of suspected or previously diagnosed brain tumor (primary or metastatic) or epileptic focus as part of routine clinical care
Willing to undergo neurosurgical resection or biopsy at Mayo Clinic (Rochester, Minnesota \[MN\])
Ability to understand and the willingness to sign a written informed consent document

Exclusion Criteria2

Vulnerable populations: pregnant women, prisoners or the mentally handicapped
Patients who are not appropriate candidates for surgery due to current or past medical history or uncontrolled concurrent illness